Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Seminars in Nuclear Medicine
|
September 23, 2025
Expanding the Horizon of Targeted Radionuclide Therapy: Immunotherapy Combinations and FAP-Targeted Approaches
Ayça Arçay Öztürk, Wendy Delbart, Patrick Flamen
Nuclear Medicine and Biology
|
April 11, 2021
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [<sup>177</sup>Lu]Lu-DOTATATE in a panel of cancer cell lines
Wendy Delbart, Ghanem E Ghanem, Ioannis Karfis, et al.
European Journal of Hybrid Imaging
|
April 19, 2022
Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case report
Ringo Manta, Wendy Delbart, Ivan Duran Derijckere, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 28, 2026
Toward Personalized Radiopharmaceutical Therapy: Radiobiologic Insights Compared with External-Beam Radiotherapy
Sébastien Penninckx, Wendy Delbart, Magdalena Mileva, et al.
International Journal of Molecular Sciences
|
October 27, 2022
Understanding the Radiobiological Mechanisms Induced by <sup>177</sup>Lu-DOTATATE in Comparison to External Beam Radiation Therapy
Wendy Delbart, Jirair Karabet, Gwennaëlle Marin, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 27, 2025
The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma
Wendy Delbart, Ioannis Karfis, Marie Vercruyssen, et al.
EJNMMI Reports
|
July 27, 2025
First-in-human experience of radiopharmaceutical therapy with [<sup>177</sup>Lu]Lu-DOTATATE in patients with advanced multiple myeloma
Wendy Delbart, Marie Vercruyssen, Rachele Danieli, et al.
EJNMMI Research
|
November 18, 2024
Evolution of dosimetric parameters through PRRT and potential impact on clinical practice: data from the prospective phase II LUMEN study
Rachele Danieli, Magdalena Mileva, Gwennaëlle Marin, et al.
Cancers
|
May 16, 2023
Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE
Wendy Delbart, Gwennaëlle Marin, Basile Stamatopoulos, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Seminars in Nuclear Medicine
|
September 23, 2025
Expanding the Horizon of Targeted Radionuclide Therapy: Immunotherapy Combinations and FAP-Targeted Approaches
Ayça Arçay Öztürk, Wendy Delbart, Patrick Flamen
Nuclear Medicine and Biology
|
April 11, 2021
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [<sup>177</sup>Lu]Lu-DOTATATE in a panel of cancer cell lines
Wendy Delbart, Ghanem E Ghanem, Ioannis Karfis, et al.
European Journal of Hybrid Imaging
|
April 19, 2022
Suspicious cold thyroid nodule with intense focal 68Ga-DOTATATE uptake: a case report
Ringo Manta, Wendy Delbart, Ivan Duran Derijckere, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 28, 2026
Toward Personalized Radiopharmaceutical Therapy: Radiobiologic Insights Compared with External-Beam Radiotherapy
Sébastien Penninckx, Wendy Delbart, Magdalena Mileva, et al.
International Journal of Molecular Sciences
|
October 27, 2022
Understanding the Radiobiological Mechanisms Induced by <sup>177</sup>Lu-DOTATATE in Comparison to External Beam Radiation Therapy
Wendy Delbart, Jirair Karabet, Gwennaëlle Marin, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 27, 2025
The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma
Wendy Delbart, Ioannis Karfis, Marie Vercruyssen, et al.
EJNMMI Reports
|
July 27, 2025
First-in-human experience of radiopharmaceutical therapy with [<sup>177</sup>Lu]Lu-DOTATATE in patients with advanced multiple myeloma
Wendy Delbart, Marie Vercruyssen, Rachele Danieli, et al.
EJNMMI Research
|
November 18, 2024
Evolution of dosimetric parameters through PRRT and potential impact on clinical practice: data from the prospective phase II LUMEN study
Rachele Danieli, Magdalena Mileva, Gwennaëlle Marin, et al.
Cancers
|
May 16, 2023
Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE
Wendy Delbart, Gwennaëlle Marin, Basile Stamatopoulos, et al.
Page
of 1